Cargando…
STC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer
BACKGROUND: Stanniocalcin-1 (STC1) is a well-studied oncogene that promotes different types of cancer progression. However, the expression status of STC1, the values of STC1 on prognosis, and its immune characteristic in bladder cancer (BLCA) have not been well examined. METHODS: The expression of S...
Autores principales: | Sun, Jiale, Wei, Xuedong, You, Jiawei, Yue, Wenchang, Ouyang, Jun, Ling, Zhixin, Hou, Jianquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445105/ https://www.ncbi.nlm.nih.gov/pubmed/34539184 http://dx.doi.org/10.2147/IJGM.S329723 |
Ejemplares similares
-
Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer
por: Sun, Jiale, et al.
Publicado: (2021) -
Prognostic values of the core components of the mammalian circadian clock in prostate cancer
por: Yue, Wenchang, et al.
Publicado: (2021) -
Data-driven translational prostate cancer research: from biomarker discovery to clinical decision
por: Lin, Yuxin, et al.
Publicado: (2020) -
Research progress of STC2 in breast cancer
por: Niu, Xuezhi, et al.
Publicado: (2021) -
The potential utility of non-invasive imaging to monitor restoration of bladder structure and function following subtotal cystectomy (STC)
por: Burmeister, David, et al.
Publicado: (2015)